New Actos ads call on current Avandia patients to switch
September 28 2010
Takeda, maker of the most heavily prescribed diabetes drug, Actos, is again capitalizing on rival Avandia's regulatory troubles in new ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.